It is worth noting that IDH1R132H inhibitor BAY1436032 collocated with PD-1 inhibitor would result in an increase of overall survival in C57BL/6 J mice bearing IDH1-mutated glioma [119]. Here, IDH1 is linked to central nervous system cancer.